Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Published on Sep 15, 2007in American Journal of Respiratory and Critical Care Medicine17.452
· DOI :10.1164/RCCM.201204-0596PP
Jørgen Vestbo120
Estimated H-index: 120
Suzanne S. Hurd19
Estimated H-index: 19
+ 10 AuthorsRoberto Rodriguez-Roisin37
Estimated H-index: 37
(University of Barcelona)
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy document for the diagnosis and management of COPD. This executive summary presents the main contents of the second 5-year revision of the GOLD document that has implemented some of the vast knowledge about COPD accumulated over the last years. Today, GOLD recommends that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation. The document highlights that the assessment of the patient with COPD should always include assessment of (1) symptoms, (2) severity of airflow limitation, (3) history of exacerbations, and (4) comorbidities. The first three points can be used to evaluate level of symptoms and risk of future exacerbations, and this is done in a way that splits patients with COPD into four categories—A, B, C, and D. Nonpharmacologic a...
Figures & Tables
📖 Papers frequently viewed together
2,771 Citations
1,962 Citations
2,085 Citations
#1Milo A. Puhan (UZH: University of Zurich)H-Index: 75
#2Elena Gimeno-SantosH-Index: 21
Last. Thierry Troosters (Katholieke Universiteit Leuven)H-Index: 81
view all 4 authors...
BACKGROUND: Pulmonary rehabilitation has become a cornerstone in the management of patients with stable Chronic Obstructive Pulmonary Disease (COPD). Systematic reviews have shown large and important clinical effects of pulmonary rehabilitation in these patients. However, in unstable COPD patients who have recently suffered an exacerbation, the effects of pulmonary rehabilitation are less established. OBJECTIVES: To assess the effects of pulmonary rehabilitation after COPD exacerbations on futur...
620 CitationsSource
We examined the relationship between breathing pattern and severity of disease in patients with chronic obstructive pulmonary disease (COPD). Resting breathing pattern was recorded for 45 min using the respiratory inductance Plethysmograph (RIP) in 22 patients with stable COPD. Six subjects (moderate group) had FEV1 25 to 50 % predicted, 8 subjects (severe group) had FEV1 < 25% predicted, and 8 subjects (respiratory failure group) had FEV1 < 25% predicted and were hypoxemic. Seven of the subject...
41 CitationsSource
We have related the red cell mass (RCM) in 47 hypoxic patients with COPD (mean P02,52.5 ± 5.2 SD mmHg; mean PC02, 51.7 ± 6.7 mmHg; mean FEV1, 0.6 ± 0.2 L; mean FVC, 1.7 ± 0.6 L) to their smoking habits and outpatient carboxyhemoglobin concentrations. The mean RCM was 42.5 ± 8.0 ml/kg in the 31 patients who still smoked, significantly (p 0.1). In 15 patients given long-term oxygen therapy (15 hours/24-hour period) for 12 months RCM decreased significantly only in those who stopped smok...
64 CitationsSource
#1Bernard McCarthy (National University of Ireland, Galway)H-Index: 8
#2Dympna Casey (National University of Ireland, Galway)H-Index: 32
Last. Yves Lacasse (Laval University)H-Index: 60
view all 6 authors...
Background Widespread application of pulmonary rehabilitation (also known as respiratory rehabilitation) in chronic obstructive pulmonary disease (COPD) should be preceded by demonstrable improvements in function (health-related quality of life, functional and maximal exercise capacity) attributable to the programmes. This review updates the review reported in 2006. Objectives To compare the effects of pulmonary rehabilitation versus usual care on health-related quality of life and functional an...
1,580 CitationsSource
#2Phillippa Poole (University of Auckland)H-Index: 32
Last. Rebecca Normansell (St George's, University of London)H-Index: 14
view all 5 authors...
Background Both long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to medication regimens and improve efficacy. Objectives To determine the efficacy and safety of combined ICS and LABA for stable COPD in comparison with placebo. Search methods We searched the Cochrane Airways Group Specialised Register of ...
268 CitationsSource
#1Phillippa Poole (University of Auckland)H-Index: 32
#2Peter N. Black (University of Auckland)H-Index: 48
Background Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Because of the personal and healthcare costs associated with exacerbations, any therapy that reduces the number of exacerbations is useful. There is a marked difference among countries in terms of prescribing of mucolytics depending on whether or not they are perceived to be effective. Objectives Primary obje...
201 CitationsSource
#1Bernd LamprechtH-Index: 23
#2Mary Ann McBurnie (UP: University of Portland)H-Index: 27
Last. Sonia Buist (OHSU: Oregon Health & Science University)H-Index: 22
view all 12 authors...
Background Never smokers comprise a substantial proportion of patients with COPD. Their characteristics and possible risk factors in this population are not yet well defined. Methods We analyzed data from 14 countries that participated in the international, population-based Burden of Obstructive Lung Disease (BOLD) study. Participants were aged ≥ 40 years and completed postbronchodilator spirometry testing plus questionnaires about respiratory symptoms, health status, and exposure to COPD risk f...
330 CitationsSource
#1Daniela Vollenweider (Johns Hopkins University)H-Index: 12
#2Harish Jarrett (TU: Temple University)H-Index: 4
Last. Milo A. Puhan (Johns Hopkins University)H-Index: 75
view all 5 authors...
Background Many patients with an exacerbation of chronic obstructive pulmonary disease (COPD) are treated with antibiotics. However, the value of antibiotics remains uncertain as systematic reviews and clinical trials have shown conflicting results. Objectives To assess the effects of antibiotics in the management of acute COPD exacerbations on treatment failure as observed between seven days and one month after treatment initiation (primary outcome) and on other patient-important outcomes (mort...
325 CitationsSource
#1Denis E. O'Donnell (Queen's University)H-Index: 87
Last. Dror OfirH-Index: 11
view all 6 authors...
Background: Symptomatic patients with GOLD stage I COPD can have significant abnormalities of ventilatory mechanics with greater exertional symptoms and exercise limitation than age-matched healthy subjects. In such patients, the impact of bronchodilator therapy remains unknown and is difficult to evaluate. Methods: We measured the acute effects of nebulized ipratropium bromide 500μg (IB) on resting pulmonary function and on dyspnoea and ventilatory parameters during symptom-limited constant wor...
86 CitationsSource
#1François MaltaisH-Index: 84
#2Jean BourbeauH-Index: 74
Last. Sarah BernardH-Index: 14
view all 19 authors...
Francois Maltais, MD; Jean Bourbeau, MD, MSc; Stan Shapiro, PhD; Yves Lacasse, MD, MSc; Helene Perrault, PhD; Marc Baltzan, MD, MSc; Paul Hernandez, MD; Michel Rouleau, MD; Marcel Julien, MD; Simon Parenteau, MD; Bruno Paradis, MD; Robert D. Levy, MD; Pat Camp, Pht, PhD; Richard Lecours, MD; Richard Audet, MD; Brian Hutton, MSc; John R. Penrod, PhD; Danielle Picard, RN; and Sarah Bernard, MSc, for the Chronic Obstructive Pulmonary Disease Axis of the Respiratory Health Network, Fonds de la reche...
279 CitationsSource
Cited By14626
#2E Liu (IMUN: Inner Mongolia University for Nationalities)
Chronic obstructive pulmonary disease (COPD) was estimated to be the third cause of global mortality by 2020. Acute exacerbation COPD (AECOPD) is a sudden worsening of COPD symptoms and could be due to virus/bacterial infections and air pollution. Increased expression of inflammatory markers in patients with AECOPD is associated with viral infection. This study aimed to detect different viruses and analyze the expression of various inflammatory markers associated with AECOPD patients. Three hund...
#1Yuji Yamamoto (Osaka University)H-Index: 4
#2Tomoki KugeH-Index: 1
Last. Hiroshi KidaH-Index: 74
view all 9 authors...
Abstract null null The association between airflow obstruction and bronchial dilation has been researched in bronchiectasis. However, the impact of bronchial wall thickening on airflow obstruction has not been thoroughly investigated. This study assessed the underlying mechanism of airflow obstruction in bronchiectasis due to abnormal bronchial wall thickening using oscillometry. null A total of 98 patients with bronchiectasis were retrospectively reviewed. At the time of diagnosis, spirometric ...
Last. A Kyren
view all 4 authors...
The airway epithelium is a complex microcosm of cells that maintain a pseudostratified structure crucial for defense against various pathogens. Small airways are the major critical zone of many lung diseases like COPD and asthma. Cells lining the small airway include ciliated, secretory, basal and neuroendocrine cells. Club cells are the prominent secretory cell type, characterized by an apical dome shape, microvilli, dense cytoplasmic granules, extensive smooth endoplasmic reticulum and mitocho...
#1Asser Elsaeed (Mansoura University)
#2Omayma Afsah (Mansoura University)H-Index: 3
Last. Tamer Abou-Elsaad (Mansoura University)H-Index: 6
view all 5 authors...
Injection laryngoplasty is a surgical procedure used in management of glottal insufficiency. The objective of this study was to assess respiratory and voice outcomes of office-based injection laryngoplasty in patients with unilateral vocal fold paralysis (UVFP). Ten patients underwent office-based injection via transcutaneous approach using Radiesse or hyaluronic acid. Auditory perceptual assessment (APA), voice handicap index (VHI), size of the glottic gap, acoustic parameters (jitter, shimmer,...
1 CitationsSource
#1Spyridon Fortis (UI: University of Iowa)H-Index: 11
#2Emily S. Wan (Brigham and Women's Hospital)H-Index: 24
Last. Alejandro P. Comellas (UI: University of Iowa)H-Index: 30
view all 11 authors...
Abstract Background The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. Methods We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations we...
1 CitationsSource
#2Srushti TambeH-Index: 1
view all 4 authors...
Abstract null null Background null The interest in the use of Eucalyptus genus members, in parallel with preclinical studies has been steadily growing over the last few decades in the field of pharmaceuticals, agriculture, cosmetics, food, etc. Eucalyptol (1,8-cineole or cineole), the main terpenoid constituent in Eucalyptus species, has been studied in both preclinical and clinical settings for its various pharmacologic activities. Investigations into the pharmacological activities of the genus...
#1Ianire Maté (Complutense University of Madrid)H-Index: 9
#2Irene Martínez de Toda (Complutense University of Madrid)H-Index: 10
Last. Mónica De la Fuente (Complutense University of Madrid)H-Index: 52
view all 5 authors...
Abstract null null Chronic obstructive pulmonary disease (COPD) is characterised by inflammatory and oxidative alterations in the lung and extrapulmonary compartments, through involvement of the immune system. Several leukocyte functions are health markers and good predictors of longevity, and high pro-inflammatory and oxidative states are related to more aged profiles. Here, we aimed to investigate the aging rate in terms of immunosenescence in COPD men with respect to healthy age-matched contr...
#1Aleksandar Dobric (RMIT: RMIT University)H-Index: 1
#2Simone N. De Luca (RMIT: RMIT University)H-Index: 7
Last. Ross Vlahos (RMIT: RMIT University)H-Index: 41
view all 7 authors...
Abstract null null Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden and currently the 3rd largest cause of death in the world, with approximately 3.23 million deaths per year. Globally, the financial burden of COPD is approximately €82 billion per year and causes substantial morbidity and mortality. Importantly, much of the disease burden and health care utilisation in COPD is associated with the management of its comorbidities and viral and bacterial-induce...
#1Priyanka Choudhury (IIT-KGP: Indian Institute of Technology Kharagpur)H-Index: 2
#2Souvik Biswas (IIT-KGP: Indian Institute of Technology Kharagpur)H-Index: 1
Last. Koel Chaudhury (IIT-KGP: Indian Institute of Technology Kharagpur)H-Index: 25
view all 9 authors...
Abstract null null Chronic obstructive pulmonary disease (COPD) and asthma are the two most common obstructive lung diseases which affects millions worldwide and impose an enormous burden on global healthcare. The overlapping features shared by these two diseases often make differential diagnosis difficult to achieve, leading to misdiagnosis of these patients. Both asthma and COPD are associated with chronic inflammation of the airways which is perpetuated by the interplay between immunological ...
#1David Jiménez (University of Alcalá)H-Index: 24
#2Alvar Agusti (University of Barcelona)H-Index: 117
Last. Aitor BallazH-Index: 11
view all 26 authors...
Importance null Active search for pulmonary embolism (PE) may improve outcomes in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD). null Objective null To compare usual care plus an active strategy for diagnosing PE with usual care alone in patients hospitalized for COPD exacerbation. null Design, setting, and participants null Randomized clinical trial conducted across 18 hospitals in Spain. A total of 746 patients were randomized from September 2014 to Ju...